A new center comprising University at Buffalo (UB) researchers in chemical, biological and biomedical engineering will develop innovative technologies for regenerative medicine and educate future leaders in the field.
Funded by the UB Provost, the Center for Cell, Gene and Tissue Engineering (CGTE) will be led by SUNY Distinguished Professor Stelios Andreadis, an expert in stem cells, tissue engineering and regenerative medicine and the director of UB’s Stem Cells in Regenerative Medicine (SCiRM) Training Program.
The Center will initially focus on several areas of core faculty expertise, including stem cell engineering, tissue engineering and regeneration; biomaterials; cell and tissue biomechanics; gene, protein and drug delivery (including novel vectors, vaccines and CRISPR technologies), novel imaging technologies; high-throughput data acquisition technologies; BioMEMS; and omics (genomics, proteomics, glycomics) and associated systems, computational and big data engineering.
“I am excited that we are able to launch the CGTE Center during such difficult times, and am looking forward to working with the core faculty on collaborations that will enrich our collective research activities as well as that of the UB scientific community at large,” says Andreadis.
The core faculty are Sriram Neelamegham, Natesh Parashurama, Sheldon Park and Blaine Pfeifer, from the Department of Chemical and Biological Engineering, and B. Rita Alevriadou, Jonathan Lovell, Yun Wu and Ruogang Zhao, from the Department of Biomedical Engineering, a joint program between the School of Engineering and Applied Sciences and the Jacobs School of Medicine and Biomedical Sciences. The Center will eventually expand to include additional faculty from SEAS as well as other UB units such the Jacobs School and the College of Arts and Sciences.